Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03060096 · ClinicalTrials.gov registry record · NA
Stepped-Care Telehealth for Distress in Cancer Survivors
A NA study of Cancer and Anxiety, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 20
- Study locations
NCT03060096: Completed NA study of Cancer and Anxiety, sponsored by Wake Forest University Health Sciences.
NCT03060096 is a NA study of Cancer and Anxiety that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 68 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03060096, a NA study of Cancer and Anxiety, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 20
- Study locations
Study Summary
Mental health issues in post-treatment adult cancer survivors are associated with multiple adverse outcomes and may represent a cancer health disparity for rural survivors. The purpose of this study is to test a stepped-care approach tailored to symptom severity based on recent American Society of Clinical Oncology guidelines for reducing emotional distress (anxiety and/or depressive symptoms) and improving secondary outcomes (sleep disturbance, fatigue, fear of recurrence, quality of life) in rural, post-treatment cancer survivors in community oncology settings and to examine intervention costs. The resultant intervention will have great potential for widespread dissemination since it will be manualized, delivered by telephone, and comprised of modules to allow customized treatments for individuals with different cancer types.
Primary Outcome
Study retention will be estimated by the number of participants who complete the Week 7 and 13 visits
Conditions Studied
Interventions
- OTHER Severe Anxiety/depression: High Intensity Stepped Care
- OTHER Moderate Anxiety/depression: Low Intensity Stepped care
- OTHER Enhanced Usual Care Control
Study Locations (20)
Illinois
- Rush - Copley Medical Center - Aurora
- Illinois CancerCare-Bloomington - Bloomington
- Illinois CancerCare-Canton - Canton
- Memorial Hospital of Carbondale - Carbondale
- SIH Cancer Institute - Carterville
- Illinois CancerCare-Carthage - Carthage
- Centralia Oncology Clinic - Centralia
- Carle on Vermilion - Danville
California
- Kaiser Permanente-Fresno - Fresno
- Kaiser Permanente-Modesto - Modesto
- Kaiser Permanente-South Sacramento - Sacramento
- Pacific Central Coast Health Center-San Luis Obispo - San Luis Obispo
- Kaiser San Rafael-Gallinas - San Rafael
- Kaiser Permanente-Santa Rosa - Santa Rosa
- Kaiser Permanente-Stockton - Stockton
Georgia
- Augusta University Medical Center - Augusta
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler - Savannah
- Low Country Cancer Care Associates PC - Savannah
- Summit Cancer Care-Candler - Savannah
Arkansas
- Mercy Hospital Fort Smith - Fort Smith
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2018-07-19 |
| Est. Completion | 2022-07-29 |
| Phase | NA |
What the finished NCT03060096 record still lists
NCT03060096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower).
The record links to 7 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Severe Anxiety/depression: High Intensity Stepped Care is the first listed.
NCT03060096 names 20 study sites across 4 states, led by Illinois, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT03060096 about?
NCT03060096 is a clinical study titled "Stepped-Care Telehealth for Distress in Cancer Survivors". Mental health issues in post-treatment adult cancer survivors are associated with multiple adverse outcomes and may represent a cancer health disparity for rural survivors. The purpose of this study is to test a stepped-care approach tailored to symptom severity based on recent American Society of C...
What is the current status of trial NCT03060096?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2018-07-19. Estimated completion is 2022-07-29.
What conditions does trial NCT03060096 study?
This clinical trial studies the following conditions: Cancer, Anxiety, Fatigue, Quality of Life, Depressive Symptoms.
What interventions are being tested in trial NCT03060096?
The interventions under investigation include: Severe Anxiety/depression: High Intensity Stepped Care (OTHER), Moderate Anxiety/depression: Low Intensity Stepped care (OTHER), Enhanced Usual Care Control (OTHER).
Who is sponsoring clinical trial NCT03060096?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03060096 being conducted?
This trial has 20 study locations across Arkansas, California, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03060096's enrollment target sits among peer trials
68 382nd of 615 higher than 232 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI